Risperidone (Risperdal): clinical experience with a new antipsychosis drug

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.8, Iss.4, 1999-04, pp. : 443-452

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacology and clinical experience with risperidone

By Love R.C. Nelson M.W.

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 7, 2000-12 ,pp. : 1441-1453

Informa Healthcare

Access to resources Recommend Favorite

Risperidone Drug Monitoring: A Useful Clinical Tool?

By Odou P.

Clinical Drug Investigation, Vol. 19, Iss. 4, 2000-04 ,pp. : 283-292

Adis International

Access to resources Recommend Favorite

Pharmacogenetics of clinical response to risperidone

By LLerena Adrián Berecz Roland Peñas-LLedó Eva Süveges Ágnes Fariñas Humberto

Pharmacogenomics, Vol. 14, Iss. 2, 2013-01 ,pp. : 177-194

Future Medicine

Access to resources Recommend Favorite

The Role of Cytochrome P450 Enzymes in the Metabolism of Risperidone and Its Clinical Relevance for Drug Interactions

Current Drug Targets, Vol. 5, Iss. 6, 2004-08 ,pp. : 573-579

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetic Profile and Clinical Efficacy of Long-Acting Risperidone: Potential Benefits of Combining an Atypical Antipsychotic and a New Delivery System

By Ereshefsky Larry

Drugs in R&D, Vol. 6, Iss. 3, 2005-01 ,pp. : 129-137

Adis International

Access to resources Recommend Favorite